deficiency

InflaRx Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

JENA, Germany, March 13, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting…

4 days ago

Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency

January 16, 2026 16:30 ET  | Source: Cellyan Biotechnology Co., Ltd HONG KONG, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Cellyan…

2 months ago

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

December 24, 2025 16:00 ET  | Source: XTL Biopharmaceuticals Ltd. RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL…

3 months ago

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder

Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure frequency (CMSF)…

3 months ago

Darkiris Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Hong Kong, Nov. 21, 2025 (GLOBE NEWSWIRE) -- DarkIris Inc. (Nasdaq: DKI) (the “Company” or “DarkIris”), a comprehensive technology enterprise…

4 months ago

Biotic innovation tackles iron deficiency in women – now recognized across three continents

STOCKHOLM, Sept. 22, 2025 /PRNewswire/ -- A health solution designed to improve iron absorption in women has garnered international acclaim,…

6 months ago